These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 14665895)

  • 1. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.
    Kaplan SA; Volpe MA; Te AE
    J Urol; 2004 Jan; 171(1):284-8. PubMed ID: 14665895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome.
    Yang J; Te AE
    Curr Urol Rep; 2005 Jul; 6(4):290-5. PubMed ID: 15978232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
    Nickel JC; Downey J; Pontari MA; Shoskes DA; Zeitlin SI
    BJU Int; 2004 May; 93(7):991-5. PubMed ID: 15142149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
    BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study.
    Falahatkar S; Shahab E; Gholamjani Moghaddam K; Kazemnezhad E
    BJU Int; 2015 Oct; 116(4):641-9. PubMed ID: 25307409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial.
    Giammusso B; Di Mauro R; Bernardini R
    Arch Ital Urol Androl; 2017 Mar; 89(1):17-21. PubMed ID: 28403589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial.
    Nickel JC; Johnston B; Downey J; Barkin J; Pommerville P; Gregoire M; Ramsey E
    Urology; 2000 Sep; 56(3):413-7. PubMed ID: 10962305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
    Wagenlehner FM; Schneider H; Ludwig M; Schnitker J; Brähler E; Weidner W
    Eur Urol; 2009 Sep; 56(3):544-51. PubMed ID: 19524353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saw palmetto for prostate disorders.
    Gordon AE; Shaughnessy AF
    Am Fam Physician; 2003 Mar; 67(6):1281-3. PubMed ID: 12674456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.
    Gerber GS; Kuznetsov D; Johnson BC; Burstein JD
    Urology; 2001 Dec; 58(6):960-4; discussion 964-5. PubMed ID: 11744467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia.
    Marks LS; Partin AW; Epstein JI; Tyler VE; Simon I; Macairan ML; Chan TL; Dorey FJ; Garris JB; Veltri RW; Santos PB; Stonebrook KA; deKernion JB
    J Urol; 2000 May; 163(5):1451-6. PubMed ID: 10751856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D; Wang P; Chen J; Wang S; Jiang H
    Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC; Narayan P; McKay J; Doyle C
    J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial.
    Choe HS; Lee SJ; Han CH; Shim BS; Cho YH
    J Infect Chemother; 2014 Jan; 20(1):20-5. PubMed ID: 24462419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome.
    Giannantoni A; Porena M; Gubbiotti M; Maddonni S; Di Stasi SM
    Urology; 2014 Feb; 83(2):400-5. PubMed ID: 24231216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
    Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
    Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids.
    Maurizi A; De Luca F; Zanghi A; Manzi E; Leonardo C; Guidotti M; Antonaccio FP; Olivieri V; De Dominicis C
    Arch Ital Urol Androl; 2019 Jan; 90(4):260-264. PubMed ID: 30655636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flower Pollen Extract in Association with Vitamins (Deprox 500®) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments.
    Macchione N; Bernardini P; Piacentini I; Mangiarotti B; Del Nero A
    Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):151-161. PubMed ID: 30488800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.